A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers

NCT06258213 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout
Acute Gout Flare
Gout Flares

Interventions

DRUG: ABP-745
DRUG: Placebo

Sponsor

Atom Therapeutics Co., Ltd